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Accumulation of damaged or misfolded proteins resulted from oxidative protein
modification induces endoplasmic reticulum (ER) stress by activating the pathways
of unfolded protein response. In pathologic hemolytic conditions, extracellular free
hemoglobin is submitted to rapid oxidation causing heme release. Resident cells of
atherosclerotic lesions, after intraplaque hemorrhage, are exposed to heme leading
to oxidative injury. Therefore, we raised the question whether heme can also provoke
ER stress. Smooth muscle cells are one of the key players of atherogenesis; thus,
human aortic smooth muscle cells (HAoSMCs) were selected as a model cell to reveal
the possible link between heme and ER stress. Using immunoblotting, quantitative
polymerase chain reaction and immunocytochemistry, we quantitated the markers of
ER stress. These were: phosphorylated eIF2α, Activating transcription factor-4 (ATF4),
DNA-damage-inducible transcript 3 (also known as C/EBP homology protein, termed
CHOP), X-box binding protein-1 (XBP1), Activating transcription factor-6 (ATF6), GRP78
(glucose-regulated protein, 78kDa) and heme responsive genes heme oxygenase-1
and ferritin. In addition, immunohistochemistry was performed on human carotid artery
specimens from patients who had undergone carotid endarterectomy. We demonstrate
that heme increases the phosphorylation of eiF2α in HAoSMCs and the expression
of ATF4. Heme also enhances the splicing of XBP1 and the proteolytic cleavage of
ATF6. Consequently, there is up-regulation of target genes increasing both mRNA and
protein levels of CHOP and GRP78. However, TGFβ and collagen type I decreased.
When the heme binding proteins, alpha-1-microglobulin (A1M) and hemopexin (Hpx)
are present in cell media, the ER stress provoked by heme is inhibited. ER stress
pathways are also retarded by the antioxidant N-acetyl cysteine (NAC) indicating that
reactive oxygen species are involved in heme-induced ER stress. Consistent with these
findings, elevated expression of the ER stress marker GRP78 and CHOP were observed
in smooth muscle cells of complicated lesions with hemorrhage compared to either
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atheromas or healthy arteries. In conclusion, heme triggers ER stress in a time- and
dose-dependent manner in HAoSMCs. A1M and Hpx as well as NAC effectively hamper
heme-induced ER stress, supporting their use as a potential therapeutic approach to
reverse such a deleterious effects of heme toxicity.
Keywords: heme, vascular smooth muscle cell, heme induced endoplasmic reticulum stress, atherosclerosis,
hemopexin, alpha-1-microglobulin
INTRODUCTION
Vascular diseases including atherosclerosis remain one of
the major causes of death worldwide (Roth et al., 2017).
Atherosclerosis is associated with various pathological
manifestations like ischemic heart disease, ischemic stroke, and
peripheral arterial disease remaining the leading public health
issue (Herrington et al., 2016). A more complete understanding
of the pathophysiology would lead to new interventions that are
urgently needed especially to treat the advanced, irreversible stage
of atherosclerosis. Type IV atherosclerotic lesions, which are
characterized by pronounced extracellular lipid accumulation,
easily progress into more complicated lesions by the rupture
of the fibrous cap and subsequent hematoma formation or
intraplaque hemorrhage (Barger et al., 1984; Stary et al., 1995;
Kolodgie et al., 2003; Moreno et al., 2006, 2012). The highly
oxidative environment of these complicated lesions contain lipid
peroxidation products such as lipid hydroperoxides, oxysterols,
aldehydes and carbonyls, which are extremely toxic to cells
of the vascular wall. Our group has been interested in this
area, especially the role of heme in the pathogenesis of plaque
progression (Balla et al., 2007).
In cell free models, heme was able to cause lipid peroxidation
characterized by extensive cross-linking with subsequent amino
acid oxidation (Gutteridge and Smith, 1988; Vincent, 1989).
Moreover, heme catalyzes the degradation of proteins to small
peptide fragments (Aft and Mueller, 1984). Our group was the
first in the literature providing evidence that free heme, having
amphipathic nature, can enter to lipid domains of living cells
sensitizing them toward any types of reactive oxygen species
(ROS) derived from activated neutrophils or inorganic-, organic
hydroperoxides leading to cell death (Balla G. et al., 1991). We
also demonstrated that oxidation of low density lipoprotein can
be highly catalyzed by free heme facilitating modification of
plasma apolipoprotein B-100 and the end products of this process
lead to vascular endothelial cell injury (Balla G. et al., 1991; Miller
and Shaklai, 1994; Li et al., 2006). The origin of the extracellular
free heme might be red blood cells (RBCs) often captured in death
zones of intraplaque hemorrhage. Plaque lipids of complicated
lesions interacts with RBCs causing hemolysis resulting in more
free heme inside of the vessel wall (Nagy et al., 2010). During
the catalytic process, the porphyrin ring opens, degrades, and
iron is liberated leading to the accumulation of footprints of
heme catalyzed oxidative reactions including oxidized lipids and
proteins, as well as cellular responses and injuries (Balla et al.,
2007; Nagy et al., 2010; Jeney et al., 2014).
The importance of protection against heme-catalyzed cell
injury is underlined by the existence of natural heme binding
proteins, which protect molecules, cells, and the whole organism
from the deleterious effects of free heme. Hemopexin (Hpx)
binds heme with a stoichiometry of one to one molar ratio with
one of the highest known affinities (Kd 10−13 M) (Hrkal et al.,
1974). Internalization of Hpx-heme complex takes place in part
via the scavenger receptor, LDL receptor-related protein1/CD91,
although not exclusively (Hrkal et al., 1974; Herz and Strickland,
2001; Hvidberg et al., 2005; Smith and McCulloh, 2015). After
intravenous injection of heme-Hpx complexes in rats, uptake
was predominantly by hepatocytes (Smith and Morgan, 1978,
1979). It is well established that in plasma and other biological
fluids binding of heme by Hpx prevents heme catalyzed oxidative
reactions such as LDL oxidation and endothelial cell death
(Gutteridge and Smith, 1988; Vincent et al., 1988; Balla G. et al.,
1991). Alpha-1-microglobulin (A1M), a radical scavenger and
reductase in the plasma and extravascular tissues, is also an
effective binder of heme (Kd 10−6 M) (Larsson et al., 2004;
Åkerström et al., 2007; Åkerström and Gram, 2014). A1M binds
heme in plasma, extravascular fluids and cells. A1M binds heme
with two binding sites, with a relatively weak one and a stronger,
covalent interaction (Larsson et al., 2004; Allhorn et al., 2005).
Several reports described the in vitro protective effects of A1M
in cell cultures against hemoglobin-, heme-, and ROS-induced
cell- and tissue damage (Olsson et al., 2008, 2011). Because these
two heme binding proteins, A1M and Hpx, protect cells and
biological molecules from heme toxicity, they have been proposed
as therapeutic agents in pathophysiological conditions where free
heme is present; and this has been established in several studies
with cell and animal models of human diseases (Schaer et al.,
2013, 2014; Vinchi et al., 2016).
The nature of the lethal cellular injury provoked by uptake
of “free” heme, i.e., non-protein bound heme is not fully
understood. At the present time, the main form of cell
death is generally considered to be necrosis caused by heme
sensitization to ROS. Heme has been reported to induce ROS
in a variety of cell types such as small intestine epithelial cells,
neutrophils, macrophages and human umbilical vein endothelial
cells provoking various pathophysiological conditions such
as intestinal mucosa dysfunction, necrosis, and inflammation
(Porto et al., 2007; Fortes et al., 2012; Barcellos-de-Souza et al.,
2013; Erdei et al., 2018). One of the major targets of ROS are
proteins leading to excessive protein modifications with often
detrimental consequences on protein structure and function
(Berlett and Stadtman, 1997; Davies, 2016). Because raising
intracellular heme can generate ROS resulting in loss off protein
functions and fragmentations (Aft and Mueller, 1984; Vincent
et al., 1988; Alvarado et al., 2015), we consider that heme-induced
ROS triggers endoplasmic reticulum stress (ER stress) together
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with unfolded protein response (UPR) through ROS-mediated
protein damage. We hypothesize that these protein modifications
might trigger ER stress and UPR. If protein folding is inhibited or
the demand for folding exceeds the folding capacity of the ER, the
pathways of UPR are activated leading to ER stress (Schröder and
Kaufman, 2005; Walter and Ron, 2011). Evidence is accumulating
for an association between vascular diseases and ER stress as
well as between atherosclerosis and oxidative stress (Ivanova and
Orekhov, 2016; Hong et al., 2017; Kattoor et al., 2017; Yang
et al., 2017). However, to date there is no evidences for the role
of ER stress in plaque progression. Furthermore, heme has not
previously been studied as a trigger of ER stress/UPR in vascular
research.
During ER stress, at least three distinct arms of the UPR are
initiated, pancreatic ER kinase-like ER kinase (PERK), activating
transcription factor-6 (ATF6), and inositol-requiring enzyme 1
(IRE1), all of which are activated by GRP78 (glucose-regulated
protein 78 kDa) (Walter and Ron, 2011). Early activation of
PERK/phosphorylated eIF2α/ATF4 pathway reduces the protein
load of the ER and enables cells to recover from this form of
stress (Hamanaka et al., 2005; Raven and Koromilas, 2008). ATF4
initiates the transcription of genes involved in the functional
UPR, including those linked to amino acid metabolism,
redox homeostasis, and even ER stress-induced apoptosis
(Harding et al., 2003; Ameri and Harris, 2008). Prolonged
or severe ER stress leads to cell death mediated by CHOP,
which is predominantly activated by the PERK/phosphorylated
eIF2/ATF4 pathway (Zinszner et al., 1998). The second major
player of ER stress is IRE1a, a proximal sensor of ER stress, splices
X-box binding protein (XBP1) mRNA by an unconventional
mechanism using its endoribonuclease activity (Tirasophon et al.,
1998; Lee et al., 2002). Canonical targets of spliced XBP1 include
ER chaperones and components of endoplasmic reticulum-
associated degradation (ERAD), which eliminate unfolded or
misfolded proteins (Acosta-Alvear et al., 2007; He et al., 2010).
Prolonged ER stress can also activate apoptosis via IRE1-ASK1-
JNK pathway (Nishitoh et al., 2002). ATF6 is a transmembrane
glycoprotein of ER. Upon ER stress, ATF6 is cleaved and a 50
kDa fragment translocates to the nucleus (Ye et al., 2000; Liu and
Kaufman, 2003). ATF6 activates the expression of a number of
genes like the ER chaperones including Grp78, Grp94, protein
disulfide isomerase, and the components of ERAD and XBP1
(Dorner et al., 1990; Haze et al., 1999; Yoshida et al., 2001; Hirota
et al., 2006; Thuerauf et al., 2007; Todd et al., 2008). Overall,
these three arms either regulate the expression of numerous genes
that restore homeostasis in the ER or may even induce apoptosis
(Walter and Ron, 2011).
Endoplasmic reticulum stress was shown to suppress the
expression of TGFβ and downstream product collagen type I.
TGFβ enhances plaque stability, reduces atherosclerotic plaque
size (Bobik, 2006; Chen et al., 2006, 2016; Bot et al., 2009;
Reifenberg et al., 2012; Hassan et al., 2018), and is limitedly
present in advanced atherosclerotic plaques (Grainger et al., 1995;
Bobik et al., 1999; McCaffrey et al., 1999).
The purpose of this study was to investigate whether free
heme, in addition to causing intracellular “heme stress” (by
raising redox active heme and iron), might also induce ER stress.
If so, this would add a new insight into the heme-mediated vessel
wall injury in the pathogenesis of atherosclerosis. One of our
goals was to demonstrate the close proximity of heme to smooth
muscle cells, and the signs of ER stress in these cells in the depth
of atherosclerotic plaques in human samples. Using in vitro cell
culture experiments we mimicked this in vivo phenomenon in
human aortic smooth muscle cells (HAoSMCs) evaluating heme
as a trigger for ER stress using changes in key target proteins of
the three arms of the UPR. The final goal was to confirm our
second hypothesis, that A1M and Hpx are efficient protectants
against this type of complex, toxic heme stress.
MATERIALS AND METHODS
Reagents
Reagents were purchased from Sigma-Aldrich (St. Louis, MO,
United States) unless otherwise specified. Hemin chloride stock
solution (2 mM) was prepared in sterile 20 mM NaOH on the
day of use for each experiment. Human recombinant wild-type
A1M was expressed in E. coli, purified and refolded as described
with an additional ion-exchange chromatography step as outlined
(Kwasek et al., 2007; Ahlstedt et al., 2015). Rabbit hemopexin was
isolated and purified as previously described (Morgan et al., 1993;
Eskew et al., 1999).
Tissue Samples
Carotid arteries from patients who underwent carotid
endarterectomy were obtained from the Department of
Surgery at the University of Debrecen. The sample collection was
approved by the Scientific and Research Ethics Committee of
the Scientific Council of Health of the Hungarian Government
under the registration number of DE OEC RKEB/IKEB 3712-
2012. Written informed consents were received from the
participants. Specimens were examined by trained pathologist
and classified according to AHA guidelines. Type I (healthy), IV
(atheromatous) and VI (complicated) lesions were selected for
further investigation.
Cell Culture
Human aortic smooth muscle cells were obtained from Cell
Applications (San Diego, CA, United States) and Lonza
(Allendale, NJ, United States). Cells were grown in low glucose
(1g/L) DMEM containing 10% FBS, 100 U/ml penicillin,
100 µg/ml streptomycin and amphotericin B. They were grown
to 90% confluence and used from passages 5 to 7. The
medium was changed every 2 days. Heme treatments were
carried out in serum- and antibiotic-free DMEM. Briefly, hemin
chloride stock solution in sterile 20 mM NaOH was diluted
in serum- and antibiotic-free DMEM. Cells were washed twice
with Hank’s Balanced Salt Solution pH 7.4 supplemented with
Ca2 + and Mg2 + (HBSS + ) and treated with different hemin
concentrations for 60 min. Cells were washed with HBSS + and
fresh DMEM with 10% fetal bovine serum (FBS) and antibiotics
were added and cells were further incubated for 3, 6, and 16 h in a
CO2 (5%) incubator. For the A1M and Hpx studies, the proteins
were added to hemin diluted in serum- and antibiotic-free
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DMEM to a concentration of 12.5µM of A1M (two heme binding
sites) and 25 µM of Hpx (one heme binding site), gently mixed
then incubated at room-temperature in the dark with gentle
agitation for 30 min. Cells treated with 1 µM of thapsigargin,
a non-competitive inhibitor of the sarco/endoplasmic reticulum
Ca2 + ATPase (SERCA) as positive controls of ER stress for 3, 6,
and 16 h.
For N-acetyl cysteine (NAC), cells were pretreated with NAC
(10 mM) in complete growth medium 1 h prior to the heme
exposure. Cells were then washed with HBSS+ and treated
with NAC (10 mM), heme (25 µM) or with NAC (10 mM)
and heme (25 µM) together for 60 min in serum-free DMEM.
HAoSMCs were then rinsed with HBSS+ and incubated in
complete growth medium alone or supplemented with NAC
(10 mM) for 3 h. ER stress markers were then analyzed with
q-RT-PCR or immunoblot as described above.
Cell Lysis and Western Blot
Cells were washed with cold phosphate buffered saline pH 7.4
then lysed with RIPA buffer containing protease and phosphatase
inhibitors (50 mM Tris pH 7.5, 150 mM NaCl, 1% Igepal CA-630,
1% Sodium-deoxycholate, 0.1% SDS, 1×Complete Mini Protease
Inhibitor Cocktail, 2 × PHOSSTOP phosphatase inhibitor
cocktail, and incubated for 15 min on ice. Lysates were clarified
by spinning at 16000 × g, 4◦C for 15 min. Protein content
was determined using the bicinchoninic acid assay (Pierce BCA
Protein Assay Kit, Thermo Fisher Scientific, Waltham, MA,
United States).
Cell extracts (30 µg protein) were electrophoresed on
10% Tris-glycine SDS-PAGE gels, then the proteins were
transferred to 0,22 µm PVDF membrane (Bio-Rad, Hercules,
CA, United States membrane) and blocked with 5% w/v BSA for
60 min. Primary antibodies against phospho-eIF2α, eIF2α, ATF4,
ATF6, XBP1s, and ferritin heavy chain (FTH) from Cell Signaling
Technology (Danvers, MA, United States) were diluted 1:1000,
while Grp78 and HO1 from Proteintech Group (Manchester M3
3WF, United Kingdom) and diluted 1:5000 in blocking solution.
In order to ascertain equivalent protein loading in the samples,
the membranes were stripped and reprobed with a mouse anti-
human GAPDH antibody (Novus Biologicals, LLC, Littleton, CO,
United States) at a dilution of 1:5000. Antigen-antibody complex
was detected by WesternBright ECL HRP substrate (Advansta,
Menlo Park, CA, United States). Protein bands were quantified
with ImageJ software and normalized to GAPDH (Rasband,
1997–2005).
RNA Isolation and XBP1 Splicing PCR
Cells were grown on six-well plates and total RNA was isolated
with Tri Reagent (Zymo Research) and reverse transcribed
using High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems Inc., Foster City, CA, United States). XBP1 and
GAPDH were amplified with Taq DNA Polymerase (Thermo
Fisher Scientific, Waltham, MA, United States). The splice variant
of XBP1 was evaluated using the primers and conditions as
described by Kosakowska-Cholody et al. (2014). Amplimers were
quantified with ImageJ software and normalized to GAPDH.
Quantitative Reverse
Transcription-Polymerase Chain
Reaction
Cells were grown on six-well plates and total RNA was isolated
and reverse transcribed as described above. ATF4, CHOP,
Grp78, and HO1 mRNA expressions were determined by
TaqMan Gene Expression Assays (Thermo Fisher Scientific,
Waltham, MA, United States) and were normalized to GAPDH
(ATF4: Hs00909569_g1; CHOP: Hs00358796_g1; Grp78:
Hs00607129_gH; HO1: Hs01110250; GAPDH: Hs02758991_g1;
TGFβ: Hs00998133_m1; collagen type I: Hs00164004_m1).
Reverse transcriptions and qPCRs were carried out using the
C1000 Thermal Cycler with CFX 96 Real Time PCR System (Bio-
Rad, Hercules, CA, United States). Relative mRNA expressions
were calculated with the 11Ct method using GAPDH as
internal control.
Confocal Microscopy
Cells on coverslips were exposed to heme in serum- and
antibiotic-free DMEM for 60 min, rinsed twice and then
cells were incubated for 3 h in DMEM containing 10% FBS
and antibiotics. Cells were fixed in 4% paraformaldehyde in
phosphate buffered saline (PBS) pH 7.4 for 15 min. Coverslips
were washed with PBS and samples were blocked with 5%
goat serum in PBS supplemented with 0.3% Triton X-100
for 60 min. Samples were then incubated with primary
antibody against CHOP (Proteintech Group Manchester M3
3WF, United Kingdom) at a 1:500 dilution or against ATF4 (Cell
Signaling Technologies, Danvers, MA, United States) at a 1:500
dilution overnight at 4◦C in antibody dilution buffer (1% BSA
in PBS supplemented with 0.3% Triton X-100). The secondary
antibody was a goat anti-rabbit IgG conjugated to Alexa Fluor R©
532 (Thermo Fisher Scientific, Waltham, MA, United States)
used at a 1:1000 dilution in antibody dilution buffer and
incubated for 60 min at room temperature. Nuclei were visualized
with Hoechst. Cells treated with 1 µM of thapsigargin for 3 h
was used as positive control. Nuclear translocation of CHOP and
ATF4 was investigated with TCS SP8 STED microscope using
Leica Application Software X (Leica, Mannheim, Germany).
Detection of Crosslinked Hemoglobin by
Western Blot
Detection of crosslinked hemoglobin in three healthy carotid
arteries and three complicated carotid lesions by Western blot
was performed as described in our previous study using HRP-
conjugated goat anti-human Hb polyclonal antibody (ab19362-1
Abcam, Cambridge, United Kingdom) at a dilution of 1:15000
(Nagy et al., 2010).
Determination of Oxidized Hemoglobin
and Heme Content in Healthy Carotid
Arteries and Complicated Carotid
Lesions
Determination of oxidized hemoglobin concentration in healthy
carotid arteries and complicated carotid lesions was performed
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according to the method of Winterbourne CC (Winterbourn,
1990). Heme measurements in tissue samples were performed as
described by Huy et al. (2005).
Immunohistochemistry
The common carotid artery specimens were fixated with
PBS buffered formaldehyde (4%) solution (4%) at pH 7.4
for 1 to 3 day – based on the size of the sample. In case of
calciphicated samples 1.0 M/l EDTA/Tris buffer was used
for the decalcification after fixation. The vascular segments
were embedded in paraffin wax, than 3–5 um thick slides
were prepared through deparaffination used by xylene and
ethanol. After inhibition of endogenous peroxidase (0.5% for
20 min) activity slides were subjected to antigen retrieval in
a buffer solution (pH 9.0, RE7119, Leica, Wetzlar, Germany).
For immunohistochemistry, samples were incubated with
Dako EnVision FLEX Peroxidase-Blocking Reagent (Dako,
Glostrup, Denmark) for 5 min in a wet chamber. Slides
were then washed with EnVisionTM FLEX Wash Buffer,
Tris-buffered saline solution containing Tween 20, pH 7.6
(± 0.1). Antigen retrieval was performed in the epitope
retrieval solution (RE-7119, Tris/EDTA–based buffer containing
surfactant, Leica, Wetzlar, Germany) at pH 9 using a pressure
cooker. Slides were then washed with distilled water and
EnVisionTM FLEX Wash Buffer, Tris-buffered saline solution
containing Tween 20, pH 7.6 (±0.1). Next slides were
incubated with CHOP (clone: rabbit polyclonal 15204-1-
AP Proteintech Group, Rosemont, IL 60018, United States)
primary polyclonal antibody at a dilution of 1:1000 used
OPTIVIEW DAB DETECTION KIT based on protocol No.
6396500001. Serial sections next slides were incubated with
GRP78/BIP antibody (clone: rabbit polyclonal 11587-1-AP
Proteintech Group, Rosemont, IL 60018, United States)
primary polyclonal antibody at a dilution of 1:2000 used
ULTRAVIEW UNIVERSAL DAB DETECTION KIT based
on protocol No. 5269806001. The intensity and distribution
of CHOP and GRP78/BIP specific immunostaining was
assessed by light microscopy (Leica DM2500 microscope,
DFC 420 camera and Leica Application Suite V3 software,
Leica). Counterstain with Gill Hematoxylin solution (105175
Merck Millipore, Billerica, MA, United States). Rinse in
running tap water for 2–5 min. Dehydrate through 95%
ethanol for 1 min, 100% ethanol for 2 × 3 min. Clear in
xylene for 2 × 5 min. The slices were coverslip with mounting
medium.
Determination of ROS
Reactive oxygen species generated by heme was measured using
the chloromethyl derivative of 2′,7′-dichlorodihydrofluorescein
diacetate (CM-H2DCFDA; Life Technologies, Carlsbad, CA,
United States). Cells were seeded in a clear- bottom black 96-
well plate overnight in DMEM medium containing 10% FBS
and antibiotics. Cells were washed three times and incubated in
HBSS+ supplemented with CM-H2DCFDA (10 µM) for 30 min
in a CO2 incubator. Cells were washed three times and incubated
with corresponding to vehicle control (VC), thapsigargin (1 µM)
ER stress positive control (PC) or with various doses of heme (1,
10, and 25 µM) for 60 min. Cells were washed thoroughly, and
fluorescence intensity was measured applying 485 nm excitation
and 530 nm emission wavelengths. In some experiments, heme
(25 µM) was pre-incubated either with hemopexin (25 µM)
or recombinant A1M (12.5 µM) in HBSS + for 30 min
before the treatments. To mitigate oxidative stress, ROS was
scavenged by the addition of NAC (10 mM) to the experimental
medium before and during the treatments. Briefly, cells were
pre-incubated with ROS scavenger NAC (10 mM) for 60 min
in HBSS+ then exposed to heme (25 µM) together with NAC
(10 mM).
Cell Viability Assay
Cell viability was determined by the MTT assay. Briefly, cells
were cultured and treated in 96-well plates for the indicated
time. Then cells were washed with PBS, and 100 µL of
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide
(0.5 mg/mL) solution in HBSS was added. After a 90-min
incubation, the MTT solution was removed, formazan crystals
were dissolved in 100 µL of DMSO and optical density was
measured at 570 nm.
Statistical Analysis
Data are shown as mean± SD. Statistical analysis was performed
by one-way ANOVA test followed by Bonferroni correction or
unpaired t-test. A value of p< 0.05 was considered significant.
RESULTS
The ER Chaperone Grp78 and Cell Death
Marker CHOP Are Both Upregulated in
Hemorrhaged Complicated Lesions
Compared to Atheromas and Healthy
Carotid Arteries
First, we analyzed whether hemorrhaged complicated lesions
show increased ER stress marker expression compared to
healthy carotid arteries or atheromas (Figure 1). Macroscopic
features and hematoxylin-eosin-stained slides covered the full
spectrum of atherosclerotic lesions within the collected carotid
endarterectomy specimens. Healthy vessels, atheromas and
complicated, freshly hemorrhagic lesions are shown. The selected
samples were stained for smooth muscle actin, Grp78 and
CHOP using immunohistochemistry. Normal appearing carotid
wall tissue showed weak level of Grp78 and CHOP expression,
mostly located to the nucleolar and perinucleolar regions.
Simple (stabile) atheromas displayed separated layers of smooth
muscle cell bunches surrounding the lipid deposition. CHOP
and Grp78 protein expression in these cells was nearly the
same compared with the healthy control carotid samples.
Ruptured, hemorrhagic complicated lesions are presented with
highly increased CHOP and Grp78 immunopositivity appearing
in both the cytoplasm and the nucleolus of the polygonal
activated smooth muscle cells in the interstitium of the
artery.
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FIGURE 1 | Expression of ER chaperone Grp78 and death signal protein CHOP in healthy carotid wall, atheromatous plaque and complicated lesion with
hemorrhage. Immunomorphological features associated with different stages of atherosclerotic process: serial sections of healthy carotis wall (Left), atheromatous
plaque (Middle) and complicated (hemorrhagic) lesion (Right column) are shown. H&E staining, SMA, CHOP and Grp78 immunohistochemistry are presented
from the same tissue areas, all pictures and all inserts with the same magnification.
Oxidation of Hemoglobin Occurs in
Complicated Lesions Resulting in
Accumulation of Free Heme
Our previous studies revealed that complicated lesions with
hemorrhage contained oxidized forms of hemoglobin (Nagy
et al., 2010). Here, we also demonstrate that in specimens
of such atherosclerotic plaques, the hemoglobin was oxidized
(methemoglobin containing ferric heme) as reflected by the
accumulation of cross-linked dimers, tetramers and multimers
(Figure 2A). As expected, methemoglobin readily released its
heme moieties (Figures 2B,C). Since cells are exposed to heme
in the complicated hemorrhaged atherosclerotic plaques, we next
addressed whether ER stress in vascular smooth muscle cells was
provoked by heme.
Heme Activates the
PERK/eIF2/ATF4/CHOP Arm of ER
Stress Sensors
CHOP is the terminal effector protein of the PERK pathway and
our first aim was to investigate its expression in HAoSMCs in
response to heme. CHOP mRNA was measured in extracts of cells
made 3, 6, and 16 h after exposure to heme (1, 10, and 25 µM).
Thapsigargin-treated (1 µM) cells were used as positive controls.
As shown in Figure 3A, heme induced CHOP mRNA expression
in a time- and dose-dependent manner. Significant enhancement
was observed after HAoSMCs were exposed to heme (10 and
25 µM) 3 h after the treatment and declined there after back to
the control level 16 h after heme treatment. Thapsigargin treated
cells showed more robust CHOP activation compared to heme
even after 16 h of incubation where heme induced CHOP levels
declined to the control level (Supplementary Figure 1). The
expression of CHOP at the protein level together with its nuclear
translocation were also assessed with immunofluorescence 3, 6,
and 16 h after heme exposure. Untreated cells as well as vehicle
controls had very low fluorescence as did the cells exposed to
low levels of heme (1 µM). Cells treated either with 10 or
25 µM of heme showed increased fluorescence signal consistent
with higher expression, and, furthermore, nuclear translocation
of CHOP 3 h after the heme exposure demonstrating ER
stress (Supplementary Figure 2). Fluorescence signals in cells
treated with 10 µM of heme markedly declined thereafter within
the next 3 h similar to the controls, while levels remained
elevated for up to 16 h in the cells exposed to 25 µM
(Supplementary Figures 3, 4). CHOP is predominantly up-
regulated via the PERK-eIF2α-ATF4 signaling branch of the
UPR; therefore, to gain a deeper insight into the mechanism
of CHOP activation in response to heme, we analyzed eIF2α
phosphorylation as well as ATF4 expression. These two proteins
are the upstream regulatory element of CHOP. Heme at 10 and
25 µM, but not 1 µM, transiently induced the phosphorylation
of eIF2α (p-eIF2α) and subsequently ATF4 expression too,
both at the mRNA and protein levels (Figures 3B–E). As
with the induction of CHOP mRNA, eIF2α phosphorylation
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FIGURE 2 | Complicated lesions contain oxidized forms of hemoglobin and
are characterized by high heme content. (A) Representative Western blot (one
out of five performed) showing Hb expression in three human healthy and
complicated carotid artery (20 µg/lane). (B) A spectral scan of human healthy
(N = 17) and complicated (N = 11) carotid artery tissue lysates were taken and
concentrations of ferriHb (µmol/L) were calculated based on the visible
spectra. Values were normalized to protein content of the tissue lysates.
∗∗∗p < 0.0001 using unpaired t-test. (C) Total heme concentrations (µmol/mg
protein) of human healthy (n = 14) and complicated (n = 11) carotid artery
tissue lysates were determined spectrophotometrically and calculated
according to the heme standard curve. ∗∗∗p < 0.0001 using unpaired t-test.
as well as ATF4 mRNA expression showed a dose- and
time dependency. Phosphorylation of eIF2α was significantly
increased 3 h after heme treatment and was only detectable 6 h
after the treatment when the highest heme doses were applied
(25 µM; Figures 3C,D). eIF2α phosphorylation as well as ATF4
expression declined to basal levels 16 h after the heme challenge
(Figure 3E). ATF4 mRNA levels showed slightly different kinetics
from CHOP mRNA expression with a peak at 3 h after 10 µM
heme treatment and remained constant up to 6 h. ATF4 levels
increased gradually up to 6 h after the treatment when HAoSMCs
were exposed to 25µM heme (Figure 3B). Accordingly, the ATF4
was translocated to the nucleus in cells incubated with heme (10
and 25 µM) further supporting activation of the PERK pathway
within 3 h after the heme exposure (Supplementary Figure 5).
Heme Also Activates the IRE1/XBP1s
Arm of ER Stress Sensors in a Time- and
Dose-Dependent Manner
Upon activation of the UPR, IRE1 IRE1α splices XBP1 mRNA
resulting XBP1s protein, which is a potent transcriptional
activator that induces expression of many UPR responsive
genes. To examine whether heme activates this arm of the
classical ER stress in addition to the PERK arm, we measured
XBP1 splicing catalyzed by activated IRE1 after challenging the
HAoSMCs with different concentrations of heme. As previously,
control cells were treated with 1 µM of thapsigargin. The
PCR results showed that heme (10 and 25 µM) induced the
activation of the canonical IRE1/XBP1s pathway in a time- and
concentration-dependent manner, which was demonstrated by a
transient increase in the ratio of XBP1 spliced (XBP1s) and XBP1
unspliced (XBP1u) levels (Figures 4A–F). IRE1/XBP1 activation
was the most pronounced 3 h after heme exposure (not shown).
The level of XBP1s mRNA markedly decreased 6 h after the
treatment when HAoSMCs were exposed to 10 µM of heme,
but remained induced when cells were treated with 25 µM of
heme (Figures 4C,D). XBP1s levels decreased to the control level
16 h after the treatment (Figures 4E,F). Neither vehicle nor low
dose heme (1 µM) activated IRE1/XBP1 pathway (Figures 4A–F)
consistent with our data on the PERK pathway. The protein
expression of the spliced form of XBP1 correlated well with
the mRNA expression and showed time- and dose-dependence
(Figures 4G–I). These findings suggest that the IRE1 pathway
was activated by a certain level of heme but transiently, in contrast
to the sustained activation of the PERK pathway.
Heme Also Activates the ATF6 Arm of ER
Stress in Time- and Dose-Dependent
Manner
ATF6 is a membrane bound transcription factor that activates
genes in response to ER stress because as unfolded proteins
accumulate. ATF6 is cleaved and its cytoplasmic domain enters
the nucleus, where it induces a set of chaperones (Grp78, Grp94,
calreticulin) that are involved in stress adaptation and survival.
To investigate whether heme induces ATF6-mediated stress
adaptive response, we assessed the extent of proteolytic activation
of ATF6 by immunoblotting. Heme at concentrations of 10 and
25 µM, but not at 1 µM, induced a dose-dependent proteolytic
activation of ATF6 (Figures 5A–F) causing a time- and dose-
dependent decrease in ATF6 protein levels. Noticeably, the ATF6
pathway was still activated 16 h after heme challenge indicating a
robust and long-lived response (Figures 5E,F). Thus, the adaptive
ATF6 pathway is also activated in response to heme.
Heme Increases the Expression of the
Grp78, an ER Chaperone
The trafficking of ATF6 from the ER to the Golgi for processing
by site 1 and site 2 proteases is controlled by the ER chaperone
BiP/Grp78. Thus, this protein is considered the master regulator
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FIGURE 3 | Heme activates the PERK/ATF4/CHOP arm of ER stress in a time- and dose-dependent manner. HAoSMCs were treated with various doses of heme
(1,10, and 25 µM) or corresponding vehicle solution to highest heme dose (25 µM) in serum-free DMEM for 60 min, then medium was changed to DMEM with 10%
FCS and antibiotics. ER stress markers were measured after 3, 6, or 16 h. Thapsigargin (1 µM) treated cells were used as positive control (A–E). (A,B) Relative
expressions of CHOP (A) and ATF4 (B) mRNA levels were determined by qRT-PCR, normalized to GAPDH and compared to the untreated controls at each time
points. UC, untreated control; VC, vehicle control; PC, positive control, thapsigargin treated. Results are presented as mean ± SD of five independent experiments
performed in duplicates. ∗∗∗p < 0.001. (C–E) Representative Western blots of whole cell lysates from five independent experiments are shown representing eIF-2
phosphorylation and ATF4 protein levels (C) 3, (D) 6, and (E) 16 h after the heme treatment. UC, untreated cells; VC, vehicle control cells; PC, positive control cells.
of ER stress as well as a remarkable chaperone that is itself
up-regulated during ER stress. Therefore, we next examined
whether or not Grp78 responded to heme. Heme treatment
increased the expression of Grp78 mRNA 3 h after heme exposure
(Figure 6A). Importantly, a trend in Grp78 mRNA induction
was apparent even in response to low dose heme (1 µM) within
3 h (Figure 6A). Grp78 mRNA levels gradually rose up to 6 h
after treatment when HAoSMCs were exposed to either 10 or
25 µM of heme (Figure 6A). Grp78 mRNA levels returned
to control levels after 16 h unless cells had been treated with
25 µM heme in which case Grp78 protein remained significantly
increased (p ≤ 0.05). Accordingly, Grp78 protein levels were
considerably up-regulated when cells were treated with heme
(10 and 25 µM) compared to control cells (Figures 6B–D).
Notably, Grp78 protein levels for heme treatments and vehicle
controls did not differ 3 h after the heme exposure showing an
induction phase of stress adaptation (Figure 6B). Parallel with
Grp78 mRNA induction, a robust increase in Grp78 protein levels
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FIGURE 4 | Heme activates the IRE1/XBP1 arm of ER stress in a time- and dose-dependent manner. Expression of spliced XBP1 (XBP1s) was measured with
RT-PCR followed by densitometric analysis of XBP1s after running PCR products on 2% agarose gel. XBP1s levels were normalized to GAPDH. (A,B) XBP1s levels
measured 3, (C,D) 6, and (E,F) 16 h after the heme challenge. Agarose gels A,C,E show one representative image of five independent experiments performed in
duplicates. Graphs B,D,F are presented as mean ± SD of five independent experiments performed in duplicates. ∗p < 0.05, ∗∗∗p < 0.001 compared to untreated
cells. (G–I) Representative immunoblots of five independent experiments showing XBP1s expression (A) 3, (B) 6, and (C) 16 h after the heme exposure. UC:
untreated control; VC: vehicle control; PC: positive control, thapsigargin treated cells.
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FIGURE 5 | Heme activates ATF6 arm of ER stress in a time- and dose-dependent manner. Proteolytic activation of ATF6 was investigated using Western blot and
quantified by densitometry (A–F). (A,B) ATF6 levels measured 3, (C,D) 6, and (E,F) 16 h after the heme challenge. Western blots (A,C,E) show one representative
image of five independent experiments. Graphs (B,D,F) are presented as mean ± SD of five independent experiments performed in duplicates. ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001 compared to untreated cells.
were detected 6 and 16 h after HAoSMCs were exposed to either
10 or 25 µM of heme (Figures 6B–D). Our results support that
the ER chaperone Grp78 responds to heme stress. Thapsigargin-
treated cells showed a more robust induction Grp78 (data no
shown).
Heme Markedly Increase Heme
Oxygenase 1 (HO1) and Ferritin Heavy
Chain Expression in HAoSMCs
To confirm and monitor the intracellular effect of heme and its
catabolism, we assessed the expression of HO1 and the translation
of ferritin heavy chain. As expected, heme markedly increased
HO1 mRNA as well as protein levels and also the iron release
from heme catabolism by HO1 induced ferritin heavy chain
levels (Figures 7A–G). The extent of HO1 induction is highly
correlated with intracellular heme levels in a concentration-
dependent fashion, and was apparent in response to 1 µM heme.
HO1 and ferritin heavy chain were still elevated 16 h after
heme treatment indicating high levels of HO1 and ferritin heavy
chain.
The Heme Binding Proteins A1M and
Hpx Attenuate the Activation of PERK,
IRE1/XBP1, and ATF6 Pathways as Well
as Grp78 Induction Protecting Against
Heme Induced ER Stress
A1M and Hpx are proteins that protect cells from heme
toxicity by acting as extracellular anti-oxidants, sequestering
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FIGURE 6 | Heme induces Grp78 expression in a time- and dose-dependent
manner. Cells were treated either with heme or vehicle as mentioned above.
Grp78 expression was measured using qRT-PCR and immunoblot (A–D).
(A) Relative expressions of Grp78 was determined by qRT-PCR, normalized to
GAPDH and compared to the untreated controls at each time points. Results
are presented as mean ± SD of five independent experiments performed in
duplicates. ∗∗p < 0.01, ∗∗∗p < 0.001. (B–D) Representative Western blots of
whole cell lysates from five independent experiments are shown representing
Grp78 protein levels (B) 3, (C) 6, and (D) 16 h after the heme treatment.
heme and limiting its chemical reactivity. Our next question
was whether recombinant A1M (rA1M) and Hpx inhibit the
ER stress and UPR pathways induced by heme. For these
experiments HAoSMCs were incubated with heme-protein
complexes produced by incubating heme (25 µM) with either
12.5 µM of rA1M (a stoichiometric molar ratio of heme:
protein of 2:1) or 25 µM of Hpx (a stoichiometric molar
ratio of heme: protein of 1:1). We analyzed ATF4, CHOP,
Grp78 and HO1 mRNA expression as well as IRE1-mediated
XBP1 splicing 3 or 16 h after challenging cells with either
heme or the heme-protein complexes. When presented as
heme-protein complexes, both rA1M and Hpx completely
attenuated ATF4, CHOP, and Grp78 mRNA expression as well as
inhibited XBP1 splicing 3 h after the treatment (Figures 8A–H,
9A,B) and markedly decreased HO1 mRNA expression at 3 h
(Figures 9C,D).
Both rA1M and Hpx prevented the phosphorylation of
two early markers of ER stress eIF2a and ATF4 at the
protein level (Figure 10A). Accordingly, rA1M and Hpx
completely inhibited the expression and nuclear translocation
of CHOP and proteolysis of ATF6 as demonstrated by
immunofluorescence staining of CHOP and densitometric
analysis of ATF6 immunoblots, respectively (Figures 10A,B and
Supplementary Figure 6). Furthermore, rA1M as well as Hpx
markedly reduced the expression of late ER stress marker Grp78
as shown in Figure 10C. At the protein level, when rA1M was
in the medium, HO1 and ferritin did not appear to be induced.
Surprisingly, the levels HO1 and ferritin heavy chain protein were
increased when Hpx was present in the medium. This contrasts
with our previous data on endothelial cells, when Hpx prevented
HO1 induction (Balla G. et al., 1991). In an earlier in vivo work,
heme-Hpx is targeted to the liver after intravenous injection in
rats (Smith and Morgan, 1979). The scavenger receptor termed
low density related lipoprotein receptor (LRP1), that binds heme-
Hpx complexes very tightly (Kd ∼4 nM, Hvidberg et al., 2005)
in vitro, has been reported to be expressed on vascular smooth
muscle cells (Okada et al., 1996; Swertfeger et al., 2002; Lillis
et al., 2005). Thus, LRP1 on these HAoSMCs may account
for some uptake of heme-HPX or, under these experimental
conditions, some heme was not bound to Hpx and entered the
cells.
Overall, these data show that both rA1M and Hpx attenuate
the activation of all ER stress pathways provoked by heme.
N-Acetyl Cysteine Attenuates ROS
Generation and ER Stress in
Heme-Exposed Cells
It was previously described that heme induces ROS in a
number of cell types (Porto et al., 2007; Fortes et al.,
2012; Barcellos-de-Souza et al., 2013; Erdei et al., 2018).
Therefore, we tested whether heme triggers ROS generation
in HAoSMCs (Figures 11A–F). As expected, heme (10 and
25 µM) induced ROS in a dose-dependent manner measured
by the CM-H2DCFDA assay (Figure 11A). Importantly, heme-
induced ROS generation was effectively inhibited by either
the ROS scavenger NAC or the extracellular heme binding
protein hemopexin and A1M (Figure 11B). Due to its
potent antioxidant properties, NAC was reported to attenuate
ROS-mediated ER stress in a number of pathologies (Porto
et al., 2007; Fortes et al., 2012; Barcellos-de-Souza et al.,
2013; Erdei et al., 2018). Thus, we investigated whether
NAC could prevent heme-induced ER stress as well. Our
results showed that NAC inhibited ATF4 mRNA expression,
significantly but not completely prevented heme-provoked
elevation of CHOP mRNA, and decreased the expression
of HO1 (Figures 11C–E). The ER stress moderating effect
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FIGURE 7 | Heme induces marked HO1 and ferritin heavy chain expression in a concentration- and time-dependent manner. Cells were treated either with heme or
vehicle as mentioned above. HO1 expression was measured using qRT-PCR and immunoblot, while ferritin heavy chain by immunoblot (A–G). (A) Relative
expressions of HO1 was determined by qRT-PCR, normalized to GAPDH and compared to the untreated controls at each time points. Results are presented as
mean ± SD of five independent experiments performed in duplicates. ∗∗∗p < 0.001. (B,D,F) Representative Western blots of whole cell lysates from five
independent experiments are shown representing HO1 and H-ferritin (FTH) protein levels (B) 3, (D) 6, and (E) 16 h after the heme treatment. (C,E,G) Densitometric
analysis of FTH expression (C) 3, (E) 6, and (G) 16 h after the heme exposure. Results are presented as mean ± SD of five independent experiments. FTH
expressions are normalized to GAPDH and compared to the untreated controls at each time points. UC, untreated control; VC, vehicle control; PC, positive control,
thapsigargin treated. ∗∗p < 0.01, ∗∗∗p < 0.001.
Frontiers in Physiology | www.frontiersin.org 12 November 2018 | Volume 9 | Article 1595
fphys-09-01595 November 16, 2018 Time: 17:16 # 13
Gáll et al. HIER Stress in HAoSMC
FIGURE 8 | A1M and Hpx attenuates ATF4 and CHOP gene induction as well as IRE1/XBP1s activation. Cells were treated with heme (25 µM) or heme + rA1M
(25 µM heme + 12.5 µM rA1M) or equimolar amonts of heme + Hpx (25 µM heme + 25 µM Hpx) for 60 min in serum-free DMEM. Medium was then replaced with
DMEM + 10% FCS and antibiotics. ATF4 and CHOP gene induction in response to heme were measured using qRT-PCR 3 and 16 h after the heme challenge
(A–D), while XBP1 splicing was assessed 3 h after the heme treatment by RT-PCR followed agarose gel electrophoresis and quantified by densitometry (E–H). (A–B)
Relative expressions of ATF4 and CHOP in response to heme and heme + rA1M complex were determined by qRT-PCR, normalized to GAPDH. ATF4 and CHOP
levels of rA1M + heme treated cells were compared to those detected in heme challenged cells. Results are presented as mean ± SD of five independent
(Continued)
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FIGURE 8 | Continued
experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test (C–D) Relative expressions of ATF4 and CHOP in response to heme and heme + Hpx
complex were determined by qRT-PCR, normalized to GAPDH. ATF4 and CHOP levels of Hpx + heme treted cells were compared to those detected in heme
challenged cells. Results are presented as mean ± SD of five independent experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (E–F) Cells
were treated with heme or heme + rA1M as described above. Expression of spliced XBP1 (XBP1s) was measured 3 h after the treatment with RT-PCR followed by
densitometric analysis of XBP1s after running PCR products on 2% agarose gel. XBP1s levels were normalized to GAPDH. Results are presented as mean ± SD of
five independent experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (G,H) Cells were treated with heme or heme + Hpx as described above.
Expression of spliced XBP1 (XBP1s) was measured 3 h after the treatment with RT-PCR followed by densitometric analysis of XBP1s after running PCR products on
2% agarose gel. XBP1s levels were normalized to GAPDH. Results are presented as mean ± SD of five independent experiments. ∗∗∗p < 0.0001 using unpaired
t-test.
FIGURE 9 | A1M and Hpx attenuates Grp78 and HO1 gene induction. Cells were treated with heme or heme + rA1M or equimolar amonts of heme + Hpx as
described in the legend to Figure 8. Grp78 and HO1 expression was measured using qRT-PCR 3 and 16 h after the treatment (A–D). (A) Relative expressions of
Grp78 in response to heme and heme + rA1M complex were determined by qRT-PCR, normalized to GAPDH. Grp78 levels of rA1M + heme treated cells were
compared to those detected in heme challenged cells. Results are presented as mean ± SD of five independent experiments performed in duplicates.
∗∗∗p < 0.0001 using unpaired t-test (B) Relative expressions of Grp78 in response to heme and heme + Hpx complex were determined by qRT-PCR, normalized to
GAPDH. Grp78 levels of Hpx + heme treted cells were compared to those detected in heme challenged cells. Results are presented as mean ± SD of five
independent experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (C) Relative expressions of HO1 in response to heme and heme + rA1M
complex were determined by qRT-PCR, normalized to GAPDH. HO1 levels of rA1M + heme treated cells were compared to those detected in heme challenged
cells. Results are presented as mean ± SD of five independent experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (D) Relative expressions
of HO1 in response to heme and heme + Hpx complex were determined by qRT-PCR, normalized to GAPDH. HO1 levels of Hpx + heme treted cells were compared
to those detected in heme challenged cells. Results are presented as mean ± SD of five independent experiments. ∗∗∗p < 0.0001 using unpaired t-test.
of NAC was pronounced at protein level as well, since
NAC inhibited the heme-induced activation of ER stress
pathways analyzed by immunoblot (Figure 11F). In addition,
NAC decreased HO1 protein levels in heme-treated cells
as well and was able to significantly, but not completely
reduce the expression and nuclear translocation of CHOP
by heme (Supplementary Figure 7). These data suggest that
heme induced ROS generation can be effectively prevented
either by capturing heme in the extracellular space by rA1M
or Hpx or by the antioxidant NAC. By lowering ROS
generation, NAC was able to inhibit heme-induced ER stress as
well.
Determination of Cell Viability of
HAoSMCs in Response to Heme
Next, we analyzed whether heme induced ER stress triggers cell
death in HAoSMCs. Cells were treated with various doses of
heme (1, 10, and 25 µM, respectively) and cell viability was tested
by MTT assay (Supplementary Figure 8). Thapsigargin (1 µM)
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FIGURE 10 | A1M and Hpx attenuates the activation of PERK and ATF6
pathways. Cells were treated with heme or heme + rA1M or equimolar
amonts of heme + Hpx as described above. Early ER stress markers
(phosphorylated eIF2α, ATF4, and ATF6) were measured with immunoblot,
while CHOP was assessed by immunofluorescence 3 h after the treatments
(A–C). Heme stress marker HO1 and FTH were measured 3 and 16 h after
the treatment. (A) Representative Western blots of whole cell lysates from five
independent experiments are shown representing ATF6 proteolysis, eIF2α
phosphorylation and subsequent ATF4 induction as well as HO1 and FTH
expression. (A) Analysis of CHOP expression and nuclear translocation in
response to heme and heme + rA1M or heme + Hpx treatment. (B) Graph
shows ATF6 proteolysis induced by heme or heme + rA1M or heme + Hpx
assessed by densitometric analysis of ATF6 immunoblots. Results are
presented as mean ± SD of five independent experiments performed in
duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (C) Representative Western
blots of whole cell lysates from five independent experiments are shown
representing Grp78, HO1, and FTH inductions 16 h after the treatment.
treated cells were used as positive control for ER stress. Our
data showed that neither heme nor the ER stressor thapsigargin
induced cell death in our experimental conditions.
Heme Decreases the Expression of
Transforming Growth Factor β (TGFβ)
and Collagen Type I in HAoSMCs
TGFβ and its downstream product collagen type I plays a pivotal
role in the maintenance and repair of the protective fibrous
cap in atherosclerotic plaques. Therefore, we next investigated
whether heme induced ER stress affects TGFβ and subsequent
collagen type I expression. Cells were treated with heme (25 µM)
or thapsigargin (1 µM) then TGFβ and collagen type I mRNA
expressions were quantified via qPCR 3, 6, and 16 h after the
treatments. Our results showed that heme (25 µM) as well
as thapsigargin (1 µM) significantly inhibited both TGFβ and
collagen type I mRNA expressions at 6 and 16 h after treatments
(Figures 12A,B). Both thapsigargin and heme increased collagen
type I mRNA expression at 3 h after heme or thapsigargin
challenge (Figure 12B). These data suggest that heme effect
on fibrotic gene expression are biphasic, and both heme and
thapsigargin markedly reduce fibrotic gene expression after an
initial induction phase.
DISCUSSION
There is increasing evidence for a link between vascular diseases
and ER stress as well as between atherosclerosis and oxidative
stress (Ivanova and Orekhov, 2016; Hong et al., 2017; Kattoor
et al., 2017; Yang et al., 2017). Several reports have demonstrated
that ER stress and UPR are involved in cardiovascular diseases
and multiple risk factors of atherosclerosis such as free
cholesterol, 7-ketocholesterol, phospholipolyzed LDL or oxidized
LDL have been described to trigger ER stress in macrophages,
vascular endothelial cells, and HAoSMCs (Pedruzzi et al., 2004;
Kedi et al., 2009; Sanson et al., 2009; Gora et al., 2010; Yao et al.,
2010; Chistiakov et al., 2014).
The purpose of our research was to assess how heme, a known
risk factor for atherosclerosis, contributes to the pathology of this
complex and prevalent cardiovascular disease.
Heme is an amphipathic iron-protoporphyrin IX molecule
that is, in part, responsible for human pathologies including
atherosclerosis (Andrade et al., 2010; Larsen et al., 2010; Nagy
et al., 2010; Nath and Katusic, 2012; Frimat et al., 2013;
Elphinstone et al., 2016). It was previously reported that heme
may mediate the oxidative degradation of proteins (Aft and
Mueller, 1984; Vincent, 1989). A recent study published by our
research group showed that the protein titin, responsible for the
passive elasticity of muscle and in the contraction of striated
muscle tissue, is sensitive to heme driven oxidation, can be
involved in the increase of the passive force of myocardium
driven by heme triggered oxidative protein modifications
(Alvarado et al., 2015). Heme, which is also capable of sensitizing
vascular endothelial cells toward ROS, and moreover, catalyzes
the oxidative modification of LDL to oxLDL, represents an
important risk factor of vessel wall injury (Balla G. et al., 1991;
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FIGURE 11 | Heme-generated ROS is involved in heme-induced endoplasmic reticulum (ER) stress. Cells were treated with heme (25 µM) alone or heme
(25 µM) + rA1M (12.5 µM) or heme (25 µM) + Hpx (25 µM) or heme (25 µM) + N-acetyl cysteine (NAC; 10 mM) as described for Figure 8 followed by the analysis of
ROS generation and ER stress marker expression (A–F). (A) Heme induced ROS generation was assessed by CM-H2DCFDA assay. Results are presented as
mean ± SD of five independent experiments. ∗∗∗p < 0.0001. (B) Inhibition of heme-induced ROS generation by Hpx, rA1M and NAC using CM-H2DCFDA assay.
Results are presented as mean ± SD of five independent experiments. ∗∗∗p < 0.0001 (C–E) Relative expressions of CHOP, ATF4 and HO1 in response to heme and
heme + NAC were determined by qRT-PCR, normalized to GAPDH. mRNA levels of heme + NAC treted cells were compared to those detected in heme challenged
cells. Results are presented as mean ± SD of five independent experiments performed in duplicates. ∗∗∗p < 0.0001 using unpaired t-test. (F) Representative
Western blots of whole cell lysates from five independent experiments are shown representing ATF6 proteolysis, XBP1s expression, eIF2α phosphorylation and
subsequent ATF4 induction as well as HO1 and FTH expression.
Frontiers in Physiology | www.frontiersin.org 16 November 2018 | Volume 9 | Article 1595
fphys-09-01595 November 16, 2018 Time: 17:16 # 17
Gáll et al. HIER Stress in HAoSMC
FIGURE 12 | Heme attenuates TGFβ and collagen type I expression in
HAoSMCs. Cells were treated with heme (25 µM) or thapsigargin (1 µM) as
described for Figure 3 and TGFβ and collagen type I mRNAs were quantified
by qRT-PCR (A,B). Relative expressions of TGFβ (A) and collagen type I (B)
mRNA levels were determined by qRT-PCR, normalized to GAPDH and
compared to the untreated controls at each time points. UC: untreated
control; PC: positive control, thapsigargin treated. Graphs (A,B) are presented
as mean ± SD of five independent experiments performed in duplicates.
∗∗∗p < 0.001 compared to untreated cells.
Jeney et al., 2002). Great number of observations confirmed
the presence of ROS injuries in atherosclerotic plaques, and
intriguingly, heme together with cell-free heme proteins are also
present in human vascular wall samples (Jeney et al., 2002,
2014; Balla et al., 2005; Nagy et al., 2010). Hemoglobin interacts
with lipid particles triggering further lipoprotein modifications
and hemoglobin oxidation. The main hemoglobin derivative is
methemoglobin readily capable to release its heme moieties to
the surrounding extracellular space (Nagy et al., 2010; Jeney et al.,
2014).
The focus of this study was to explore the role of heme
in ER stress in HAoSMCs, since these cells are central
players of vascular diseases. They mainly exist in a contractile
phenotype regulating vascular tone and express a variety
of HAoSMC-specific contractile markers, including α-smooth
muscle action (SMA) and calponin (Owens, 1995). However,
in response to injury, HAoSMCs can undergo a phenotypic
switch that is characterized by reduced contractile marker
expression and increased proliferation (Rensen et al., 2007). This
conversion plays a pathophysiologic role in the development of
atherosclerosis (Rzucidlo et al., 2007). However and alternatively,
it might be beneficial during atherogenesis to compensate for the
loss of HAoSMC due to apoptosis and subsequent inflammation
(Bennett et al., 2016). Thus, a considerable body of evidence
suggests that HAoSMCs are key players in vascular diseases,
which makes them an ideal target to examine the potential role
of heme-induced ER stress in atherosclerosis.
Here, we show for the first time that heme induces ER stress
and the UPR in HAoSMCs. The different arms of ER stress
were followed after heme treatment in a series of cell culture
experiments. Our results support that heme activated all three
ER stress responsive branches: PERK-eIF2α, IRE1α-XBP1, and
ATF6 pathways. Specifically, HAoSMC cultures responded to
heme by the activation of ATF6 and IRE1α-XBP1 pathways
as well as through an increase in eIF2α phosphorylation and
subsequent ATF4 induction via the PERK pathway. Increased
levels of Grp78 as well as ATF6 activation in response to heme
suggest a triggering of the adaptive phases of the cellular stress
response. No cytotoxicity was detected in response to heme via
MTT assay.
Phosphorylation of eiF2α and ATF4 expression in response
to heme possibly indicate that heme triggered oxidative stress
together with ER stress in HAOSMCs. ATF4 is a Janus faced
factor, since ATF4-mediated integrated stress response, initiated
by eIF2α phosphorylation, has been shown to protect cells against
oxidative stress (Harding et al., 2003). These observations suggest
that ATF4, a marker of ER stress and UPR, might be directly
involved in the heme stress response. These results support
our hypothesis that heme-induced ROS and oxidative stress are
involved in heme-induced ER stress. Heme was reported to
enhance the generation of ROS in a variety of cell types which
might be involved in heme-related pathologies (Porto et al.,
2007; Fortes et al., 2012; Barcellos-de-Souza et al., 2013; Erdei
et al., 2018). One of the major targets of ROS are proteins
leading to excessive protein modifications with often detrimental
consequences for protein structure and hence function (Berlett
and Stadtman, 1997; Ehrenshaft et al., 2015; Davies, 2016). We
heve demonstrated that heme does induce ROS formation in
a concentration-dependent manner in HAoSMCs. Furthermore,
by decreasing the ROS level, NAC markedly inhibited heme-
induced ER stress in HAoSMCs showing that ROS formation
contributed to ER stress triggered by heme.
ATF4 subsequently activates CHOP, a pro-apoptotic protein
(Oyadomari and Mori, 2004). Our results on CHOP induction in
response to heme correlates well with studies reporting activation
of PERK/eIF2α/ATF4/CHOP pathway in a response to oxidized
LDL, which, like heme, is considered a pathological factor of
atherosclerosis (Hong et al., 2014; Tao et al., 2016). In addition,
a strongly positive correlations between CHOP expression and
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FIGURE 13 | Mechanism of heme induced ER stress with possible therapeutic interventions. Heme released from oxidized hemoglobin enters into cells across the
plasma membrane (by unknown mechanisms) possibly via passive diffusion or transporters (remains to be defined) and induces ROS intracellularly with subsequent
protein oxidative damage that leads PERK activation, phosphorylation of eIF2α with subsequent ATF4 as well as CHOP induction and nuclear translocation.
Oxidation of Keap1 releases Nrf2, which PERK is known to phosphorylate Keap1/Nrf2 followed by nuclear translocation of Nrf2, which interacts with various targets
and possibly influences CHOP expression directly as well as indirectly. For example, Nrf2 might directly inhibit ATF4 binding to CHOP promoter thereby inhibiting
ATF4-mediated CHOP expression. Nrf2 also induces HO1, one of the key heme responsive genes. HO1 decreases the heme burden of cells and releases heme
catabolites such as carbon-monoxide (CO), biliverdin (which is converted to the antioxidant bilirubin by biliverdin reductase in the cytosol), and iron (Fe2+). CO might
inhibit CHOP expression, which suggests that Nrf2 may negatively influence CHOP in an indirect, HO1-mediated way as well. Activation of XBP1s through IRE1 in
response to heme possibly induces ER-associated protein degradation (ERAD), which decreases misfolded protein loads and reduces unfolded protein burden of
ER. Heme-induced activation of ATF6 also facilitates chaperone expression like Grp78 increasing the folding capacity of ER. Thus, heme potentially activates both
pro-apoptotic and pro-survival ER responses, however, our data support that the pro-apoptotic response is only transitory, while pro-survival ones (ATF6, Grp78) are
permanently activated. The observed marked induction of heme responsive genes as well as ER stress responsive genes suggest that these pathways interact with
each other to cope with heme-induced stress. Finally, capturing heme in the extracellular space by the heme binding proteins alpha-1-microglobulin and hemopexin
or decreasing reactive oxygen species level by NAC attenuate heme-induced ER stress.
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the progression of atherosclerosis in human coronary arteries
and carotid lesions as well as ApoE−/− mice have been reported
during the past few years (Myoishi et al., 2007; Thorp et al.,
2009; Tsukano et al., 2010). Several lines of evidence suggested
that IRE1/XBP1 activation are likely involved in vascular diseases
(Zeng et al., 2009; Liberman et al., 2011). We observed after
HAoSMCs were incubated with heme that the IRE1/XBP1
pathway was activated, but only transiently. We propose that
XBP1 activation might act as a pro-survival signal for HAoSMCs
through the activation of ER-associated degradation (ERAD)
to reduce misfolded protein loads. In addition, the adaptive
ER stress response involves initiation of the ATF6 arm, which
induces a number of chaperones such as Grp78, Grp94, and
calreticulin (Okada et al., 2002). One potential beneficial effect of
ATF6 activation is supported by a recent study showing that ATF6
decreases myocardial ischemia/reperfusion damage (Jin et al.,
2017). The sustained activation of ATF6 pathway observed in
response to heme suggests that ATF6 might facilitate the recovery
from ER stress. Grp78, the master regulator of ER stress, is a pro-
survival factor and a representative chaperone of adaptive ER
stress response (Rutkowski et al., 2006). Under oxidative stress
Grp78 could be protective (Yu et al., 1999; Jiang et al., 2017).
Here, we revealed that heme induces the sustained and robust
up-regulation of Grp78. Therefore, our data support that Grp78
together with other chaperones, possibly induced by ATF6, could
potentially contribute to cell survival during heme-induced ER
stress, depending upon the levels of heme.
The protective HO1/ferritin system is induced for heme
catabolism that releases Fe(II) in cells in response to heme
and hemoglobin (Balla J. et al., 1991; Vercellotti et al., 1994).
Thus, as expected we detected a robust induction of HO1 and
ferritin in HAoSMCs after incubation with heme. Significantly,
our data show that high levels of heme can occur in localized
hemolytic conditions in atherosclerosis. ER stress develops in
spite of the normally protective response of proteins involved
in heme trafficking to HO1 in the ER. Intriguingly, several
lines of evidence support that there is a direct interaction
between HO1, the key player of heme stress, and PERK, a
representative kinase of canonical in ER stress. In the cytosol,
Nrf2, which is a key transcriptional activator of the HO1
gene, is a direct substrate of PERK. Thus, upon ER stress
Nrf2 is released from Keap1 in the cytosol and phosphorylated
by PERK. Phospho-Nrf2 then translocates into the nucleus
where it acts to induce a number of stress responsive genes in
addition to HO1, such as glutathione S-transferase and the rate
limiting enzyme in glutathione biosynthesis, glutamylcysteine
synthetase (Venugopal and Jaiswal, 1996; Wild et al., 1999;
Nguyen et al., 2000; Cullinan et al., 2003; Loboda et al.,
2016). Activation of this Nrf2 pathway is independent of
eIF2α phosphorylation and promotes cell survival upon, and
also after, ER stress (Cullinan et al., 2003; Cullinan and
Diehl, 2004). These findings demonstrate that PERK initiates
two parallel ways to cope with ER stress, one of which
(HO1/ferritin) is also at least part of the traditional pathway
of heme stress. Interestingly, there are multiple links between
Keap1/Nrf2/HO1 and PERK pathways, since Nrf2 and the
downstream protein of PERK arm, ATF4, share certain gene
targets (Thimmulappa et al., 2002; Kwak et al., 2003; Lee et al.,
2003) including CHOP, a key regulator of ER stress. Nrf2
inhibits CHOP expression, whereas ATF4 promotes it (Harding
et al., 2000; Ma et al., 2002; Cullinan and Diehl, 2004).
Certain regulatory effects may be cell type specific. Zong and
collaborators demonstrated that Nrf2 affected CHOP expression
by modulating the binding of ATF4 to the CHOP promoter in
thyroid cancer cells, and the accumulation of Nrf2 negatively
regulated CHOP induction (Zong et al., 2012). These authors
concluded that Nrf2 might inhibit the binding of ATF4 to CHOP
promoter.
Another possible interaction between the effects of raising
intracellular heme levels/heme stress and ER stress is the key
enzyme that lowers intracellular heme, HO1, which catalyzes
heme degradation to carbon monoxide, biliverdin (which is
converted to bilirubin) and free Fe(II) iron. Liu et al. (2005)
suggested that HO1 may inhibit CHOP transcription by
modulating the level of carbon monoxide. HO1 is known to
be induced during ER stress triggered by various perturbants
such as brefeldin A, thapsigargin, and homocysteine. Apoptosis
provoked by these stressors/stresses was potentiated by HO1
inhibition, which shows that HO1 contributes to cell survival
during ER stress (Liu et al., 2005). Significantly, these published
data support a mechanism whereby heme-induced ER stress
can rescue cells from CHOP-mediated cells death. This would
take place by a direct inhibition of ATF4 binding to CHOP
promoter and by an HO1-related carbon monoxide mediated
way. Our current understanding on HIER stress in summarized
in Figure 13.
There are extracellular protective agents against heme-
induced ER stress. For example, the potential therapeutic efficacy
of the heme binding protein Hpx against heme toxicity has been
shown in patients (Janz et al., 2013; Schaer et al., 2013; Jung
et al., 2015). Also, there are animal models of various human
diseases such as severe sepsis as well as hemolytic mice models
where heme mediated damages are pronounced (Larsen et al.,
2010; Vinchi et al., 2013; Smith and McCulloh, 2015). Moreover,
Hpx prevents macrophage inflammatory activation which can
contribute to chronic tissue injury in hemolytic disorders (Vinchi
et al., 2016). In our present study Hpx completely prevented ER
stress induced by heme. Also, the protective effect of Hpx against
heme-catalyzed cytotoxicity in human and bovine endothelial
cells was previously demonstrated by us when heme uptake
and heme potentiated H2O2- and polymorphonuclear leukocyte-
mediated cytotoxicity were completely blocked when Hpx was
added simultaneously and levels that stoichiometrically bound
heme (Balla G. et al., 1991). Here, we found that Hpx acting as
an extracellular antioxidant significantly inhibited heme induced
ER stress but not HO1/ferritin expressions, which may be due
in part to expression of the heme-Hpx binding protein LRP1
The cytoprotective effect of Hpx is reinforced by a study on
neuronal cells, where free heme decreased cell survival, while
heme complexed with Hpx did not trigger cell death even
at supraphysiological concentrations (Li et al., 2009). After
endocytosis, heme-Hpx complexes induce HO1 expression in
mouse hepatoma, in HL60 cells as well as in mouse primary
neurons, where data showed that HO1 expression is required
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for Hpx-mediated cytoprotection (Alam and Smith, 1989; Alam
et al., 1999). In vivo studies in rats implicated the liver as the
main organ for uptake of heme-hemopexin complexes (Smith
and Morgan, 1978). However, it is worth mention that the
Hpx bound heme in phosphate buffered saline (PBS pH 7.4)
in vitro to ∼ 100% after addition of 1 molar equivalent of stock
mesoheme in DMSO. The efficiency of heme binding generally
the same for both proto- and meso-heme. Thus, it is unexpected
to see HO1 and ferritin induction that would indicate and excess
of heme in the mixture in the cell experimental medium of
heme and Hpx. Because the Hpx preparation was determined
to bind heme in PBS in vitro to ∼ 100% after addition of
1 molar equivalent of stock mesoheme in DMSO to 1 molar
equivalent of Hpx, the potential free heme in the experimental
medium causing unexpected HO1 and ferritin expression is
attributed to the experimental medium and conditions which
are different from the in vitro efficacy of heme binding potential
of Hpx. On the other hand, HAoSMCs are thought to express
the scavenger receptor LRP1 that binds heme-Hpx (Okada
et al., 1996; Swertfeger et al., 2002; Hvidberg et al., 2005; Lillis
et al., 2005) so some endocytosis of heme-Hpx may have taken
place, leading to the unexpected HO1 and H-Ferritin expression.
Moreover, it might be beneficial that Hpx allowed the activation
of the endogenous, protective HO1/ferritin heavy chain system
to cope with further stress stimuli. In our present research,
we have also shown that A1M inhibited heme induced ER
stress. Overall, our research further bolster up the feasibility of
Hpx-based therapeutics in diverse pathologies in which heme-
mediated tissue damage plays an etiopathogenetic role and the
potential therapeutic role of A1M in diseases where free heme/Hb
is present. In other in vitro models, A1M hindered intracellular
oxidation and upregulation of HO1 induced by heme in primary
keratinocytes also in erythroid cell line, K562 (Olsson et al., 2008,
2011). A1M prevented cell lysis of K562 cells caused by heme
and cleared the cells from bound heme. Similar effects have been
described in heme-treated skin explants (Olsson et al., 2008,
2011).
We have also confirmed that significant amounts of heme
accumulate in complicated atherosclerotic plaques. It has been
demonstrated that cell-free Hb is present in ruptured atheromas
and exists in oxidized forms. We observed that HAoSMCs, even
those at quite a distance from the border of intraplaque bleeding,
showed the characteristics of ER stress with marked expression
of ER stress/UPR marker Grp78 and CHOP. Therefore, our data
underline the importance of a new phenomenon; the presence of
unique sanctuary areas in complicated lesions, where excess free
hemoglobin and heme most likely interact with cells leading to
excessive protein modifications with hallmarks of ER stress and
UPR. These data indicate that excess heme present in complicated
lesions might trigger ER stress in vivo.
A body of evidence suggest that TGFβ promotes plaque
stability and reduces atherosclerotic plaque size (Bobik, 2006;
Chen et al., 2006, 2016; Bot et al., 2009; Reifenberg et al.,
2012; Hassan et al., 2018). In addition, inhibition of TGFβ
signaling accelerates atherosclerosis, decreases collagen synthesis
and induces hemorrhages and iron deposition (Mallat et al.,
2001; Lutgens et al., 2002). Overall, factors that decrease collagen
synthesis in HAoSMCs greatly affect their ability to maintain the
protective fibrous cap in atherosclerotic lesions. TGFβ signaling
is negatively influenced by HO1, the key effector protein of heme
catabolism in hepatocellular carcinoma cells (Park et al., 2018).
In NIH3T3 and human lung fibroblasts, TGFβ-induced collagen
synthesis is inhibited by quercetin in a HO1-dependent fashion
(Nakamura et al., 2011). Furthermore, TGFβ-mediated collagen
synthesis is impaired by HO1 in atrial fibroblast (Yeh et al., 2016).
Heme impairs TGFβ production in human mononuclear cells
in Zn/Cu superoxide dismutase-dependent manner (Andrade
et al., 2010). These data show that heme can inhibit both TGFβ
production and the signaling cascade downstream of TGFβ,
thereby regulating TGFβ responsive genes such as collagen. In
addition, TGFβ signaling was markedly inhibited by the ER stress
inducer thapsigargin in NIH3T3 and oligodendroglial OLI-neu
cell lines (Alevizopoulos et al., 1997; Ming et al., 2010). ER
stressor thapsigargin inhibited collagen synthesis as well in chick
embryo chondrocytes (Clark et al., 1994). The modulatory effect
of heme on TGFβ synthesis and signaling including collagen
production can be mediated either by the induction of HO1,
SOD, or, similar to thapsigargin, in an ER stress catalyzed way.
Active TGFβ and its receptors are limitedly expressed in isolated
areas of advanced atherosclerotic lesions together with lower
serum levels in atherosclerosis (Grainger et al., 1995; Bobik
et al., 1999; McCaffrey et al., 1999). These findings suggest that
heme induced ER stress might contribute to lower expression of
TGFβ and collagen type I resulting in plaque instability. We may
conclude that our new observation related to fibrogenesis and
heme effects are strongly supported by other models.
We demonstrate for the first time that heme induces ER stress
and UPR in HAoSMCs. Heme is such a robust stress for cells, that
it is able to induce CHOP, a pro-apoptotic protein. At the same
time we were able to show, that heme induced only a transient
increase in ATF4 with a concomitant sustained expression of
Grp78 and ATF6 activation indicating an adaptive response to ER
stress. Parallel with that, sustained activation of HO1 and ferritin
heavy chain were observed in HAoSMCs in response to heme.
CONCLUSION
Our findings provide in vivo as well as in vitro evidence that heme
triggers ER stress that might be a novel coordinated program of
responses to heme: “heme induced endoplasmic reticulum” stress
(HIER stress). We demonstrated, that the cytotoxic and harmful
effects of heme were attenuated by Hpx and A1M through their
heme binding capability. Our results support those efforts where
Hpx and A1M could serve as therapeutic agents in various
diseases where excess heme is present.
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